Balchem Analyst Ratings
Buy Rating Affirmed for Balchem With Strong Q1 Performance and Positive Growth Outlook
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $135
Balchem Analyst Ratings
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $165
Balchem Analyst Ratings
HC Wainwright Adjusts Price Target on Balchem to $150 From $140, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN) and Balchem (BCPC)
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $150
HC Wainwright Adjusts Price Target on Balchem to $140 From $152, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140
HC Wainwright Adjusts Price Target on Balchem to $152 From $164, Maintains Buy Rating
Balchem Analyst Ratings
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152
H.C. Wainwright Sticks to Its Buy Rating for Balchem (BCPC)
Balchem (BCPC) Gets a Buy From H.C. Wainwright
Balchem Is Maintained at Buy by HC Wainwright & Co.
Balchem Price Target Raised to $164.00/Share From $152.00 by HC Wainwright & Co.
HC Wainwright Adjusts Balchem's Price Target to $164 From $152, Reiterates Buy Rating
H.C. Wainwright Remains a Buy on Balchem (BCPC)